deltatrials
Completed OBSERVATIONAL NCT02015273

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ (ECOS Taiwan, Indonesia, Singapore) (ECOS TW ID SG)

Easypod Connect: a Multinational, Multicentre, Observational Study to Study Adherence and Long Term Outcomes of Therapy in Paediatric Subjects Using easypodTM Electromechanical Device for Growth Hormone Treatment

Sponsor: Merck KGaA, Darmstadt, Germany

Conditions Growth Disorders
Interventions easypod™
Updated 10 times since 2017 Last updated: Jul 3, 2020 Started: Feb 28, 2014 Primary completion: Dec 31, 2015 Completion: Dec 31, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02015273, this observational or N/A phase trial focuses on Growth Disorders and remains completed. Sponsored by Merck KGaA, Darmstadt, Germany, it has been updated 10 times since 2014, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Jan 2018 · 12 months · monthly snapshotCompleted~Jan 2018 – ~Apr 2018 · 3 months · monthly snapshotCompleted~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2019 · 7 months · monthly snapshotCompleted~Jan 2019 – ~Aug 2020 · 19 months · monthly snapshotCompleted~Aug 2020 – ~Jan 2021 · 5 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

10 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed

  2. Sep 2024 — Sep 2025 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Jan 2021 — Jul 2024 [monthly]

    Completed

  5. Aug 2020 — Jan 2021 [monthly]

    Completed

▶ Show 5 earlier versions

  1. Jan 2019 — Aug 2020 [monthly]

    Completed

  2. Jun 2018 — Jan 2019 [monthly]

    Completed

  3. Apr 2018 — Jun 2018 [monthly]

    Completed

    Phase: NA → None

  4. Jan 2018 — Apr 2018 [monthly]

    Completed NA

  5. Jan 2017 — Jan 2018 [monthly]

    Completed NA

    First recorded

Feb 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Merck KGaA, Darmstadt, Germany
  • Merck Ltd., Taiwan
  • Merck Pte. Ltd., Singapore
  • PT Merck Tbk., Indonesia, an affiliate of Merck KGaA, Darmstadt, Germany
Data source: Merck KGaA, Darmstadt, Germany

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations